MCSC study: a new drug for the treatment of Hodgkin's lymphoma
NewsDear patients!
Today MCSC is conducting an international clinical trial of a new drug for the treatment of Hodgkin's lymphoma.
We invite you to take part!
- your age is under 60
- You have been diagnosed with classic Hodgkin's lymphoma
- you have completed at least 2 lines of therapy, including after auto-HSCT (hematopoietic stem cell transplantation)
No special training is required.
What do we offer?
- free use of a new investigational drug
- full medical supervision by leading specialists-hematologists
- modern diagnostics and laboratory tests
- individual approach and safety in accordance with international protocols
You can find out more details and get advice from our coordinators by mail: OgannisyanAA1@zdrav.mos.ru
Your contribution is a step towards creating the medicines of the future!
